{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:45:44Z","timestamp":1782222344092,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05329-5","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:48:16Z","timestamp":1749210496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Undifferentiated pleomorphic sarcoma invading thoracic aorta treated by thoracic endovascular aortic repair: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Haiyang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"5329_CR1","doi-asserted-by":"publisher","first-page":"1109491","DOI":"10.3389\/fgene.2023.1109491","volume":"14","author":"H Sun","year":"2023","unstructured":"Sun H, Liu J, Hu F, Xu M, Leng A, Jiang F, Chen K. Current research and management of undifferentiated pleomorphic sarcoma\/myofibrosarcoma. Front Genet. 2023;14:1109491. https:\/\/doi.org\/10.3389\/fgene.2023.1109491.","journal-title":"Front Genet"},{"issue":"11","key":"5329_CR2","first-page":"6","volume":"16","author":"S Zhang","year":"2018","unstructured":"Zhang S, Shengji Yu. Advances in clinical research of undifferentiated pleomorphic sarcoma. Oncol Progr. 2018;16(11):6.","journal-title":"Oncol Progr"},{"key":"5329_CR3","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/BF03217830","volume":"46","author":"S Takamori","year":"1998","unstructured":"Takamori S, Hayashi A. Resection of malignant fibrous histiocytoma invading the thoracic aorta. Jpn J Thorac Cardiovasc Surg. 1998;46:825\u20138.","journal-title":"Jpn J Thorac Cardiovasc Surg"},{"key":"5329_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.soc.2022.03.006","volume":"31","author":"AM Crago","year":"2022","unstructured":"Crago AM, Cardona K. Management of myxofibrosarcoma and undifferentiated pleomorphic. Sarcoma Surg Oncol Clin N Am. 2022;31:419\u201330.","journal-title":"Sarcoma Surg Oncol Clin N Am"},{"issue":"8","key":"5329_CR5","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1586\/era.09.76","volume":"9","author":"I Matushansky","year":"2009","unstructured":"Matushansky I, Charytonowicz E, Mills J, et\u00a0al. MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st century. Expert Rev Anticancer Ther. 2009;9(8):1135\u201344.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"5329_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/his.12267","volume":"64","author":"CD Fletcher","year":"2014","unstructured":"Fletcher CD. The evolving classification of soft tissue tumours\u2014An update based on the new 2013 WHO classification. Histopathology. 2014;64(1):2\u201311.","journal-title":"Histopathology"},{"key":"5329_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.humpath.2022.02.006","volume":"123","author":"Y Cui","year":"2022","unstructured":"Cui Y, Han L, Shang J, Fang W, Zhao M, Chen D, et\u00a0al. Primary cardiac undifferentiated pleomorphic sarcoma is associated with TP53 mutation during lack of MDM2 amplification, and targeted sequencing analysis reveals potentially actionable targets. Hum Pathol. 2022;123:113\u201322. https:\/\/doi.org\/10.1016\/j.humpath.2022.02.006.","journal-title":"Hum Pathol"},{"issue":"5","key":"5329_CR8","first-page":"3393","volume":"26","author":"M Hakozaki","year":"2006","unstructured":"Hakozaki M, Hojo H, Sato M, Tajino T, Yamada H, Kikuchi S, et\u00a0al. Establishment and characterization of a new cell line, FPS-1, derived from human undifferentiated pleomorphic sarcoma, overexpressing epidermal growth factor receptor and cyclooxygenase-2. Anticancer Res. 2006;26(5):3393\u2013401.","journal-title":"Anticancer Res"},{"issue":"2","key":"5329_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s0165-4608(99)00178-8","volume":"118","author":"A Simons","year":"2000","unstructured":"Simons A, Schepens M, Jeuken J, Sprenger S, van de Zande G, Bjerkehagen B, et\u00a0al. Frequent loss of 9p21 (p16(INK4A)) and other genomic imbalances in human malignant fibrous histiocytoma. Cancer Genet Cytogenet. 2000;118(2):89\u201398. https:\/\/doi.org\/10.1016\/s0165-4608(99)00178-8.","journal-title":"Cancer Genet Cytogenet"},{"issue":"10","key":"5329_CR10","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1158\/2159-8290.CD-15-1481","volume":"6","author":"T Okada","year":"2016","unstructured":"Okada T, Lee AY, Qin LX, Agaram N, Mimae T, Shen Y, et\u00a0al. Integrin-\u03b110 dependency identifies RAC and RICTOR as therapeutic targets in highgrade myxofibrosarcoma. Cancer Discov. 2016;6(10):1148\u201365. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-1481.","journal-title":"Cancer Discov"},{"issue":"12","key":"5329_CR11","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1158\/0008-5472.CAN-17-2011","volume":"78","author":"D Shiraishi","year":"2018","unstructured":"Shiraishi D, Fujiwara Y, Horlad H, Saito Y, Iriki T, Tsuboki J, et\u00a0al. CD163 is required for protumoral activation of macrophages in human and murine sarcoma. Cancer Res. 2018;78(12):3255\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2011.","journal-title":"Cancer Res"},{"issue":"12","key":"5329_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1111\/ddg.13708","volume":"16","author":"K Welsch","year":"2018","unstructured":"Welsch K, Breuninger H, Metzler G, Sickinger F, Eberle FC, H\u00e4fner HM, et\u00a0al. Patterns of infiltration and local recurrences of various types of cutaneous sarcomas following three-dimensional histology. J Ger Soc Dermatol. 2018;16(12):1434\u201342. https:\/\/doi.org\/10.1111\/ddg.13708.","journal-title":"J Ger Soc Dermatol."},{"issue":"2","key":"5329_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijrobp.2018.05.055","volume":"102","author":"R Boughzala-Bennadji","year":"2018","unstructured":"Boughzala-Bennadji R, Stoeckle E, Le Pechoux C, et\u00a0al. Localized myxofibrosarcomas: roles of surgical margins and adjuvant radiation therapy. Int J Radiat Oncol Biol Phys. 2018;102(2):399\u2013406.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"5329_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.03.026","volume":"42","author":"V Kainhofer","year":"2016","unstructured":"Kainhofer V, Smolle MA, Szkandera J, Liegl-Atzwanger B, Maurer-Ertl W, Gerger A, et\u00a0al. The width of resection margins influences local recurrence insoft tissue sarcoma patients. Eur J Surg Oncol J. 2016;42(6): 899906. https:\/\/doi.org\/10.1016\/j.ejso.2016.03.026.","journal-title":"Eur J Surg Oncol J"},{"issue":"7","key":"5329_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1080\/0284186X.2017.1315173","volume":"56","author":"RJ Young","year":"2017","unstructured":"Young RJ, Liti\u00e8re S, Lia M, Hogendoorn PCW, Fisher C, Mechtersheimer G, et\u00a0al. Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study. Acta Oncol Stockh Swed. 2017;56(7):1013\u201320. https:\/\/doi.org\/10.1080\/0284186X.2017.1315173.","journal-title":"Acta Oncol Stockh Swed"},{"key":"5329_CR16","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.2147\/DDDT.S92395","volume":"9","author":"R De Sanctis","year":"2015","unstructured":"De Sanctis R, Marrari A, Marchetti S, Mussi C, Balzarini L, Lutman FR, et\u00a0al. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipoand leiomyosarcoma. Drug Des Dev Ther. 2015;9:5785\u201391. https:\/\/doi.org\/10.2147\/DDDT.S92395.","journal-title":"Drug Des Dev Ther"},{"issue":"6","key":"5329_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.neo.2017.03.004","volume":"19","author":"L Martinez-Cruzado","year":"2017","unstructured":"Martinez-Cruzado L, Tornin J, Rodriguez A, Santos L, Allonca E, FernandezGarcia MT, et\u00a0al. Trabectedin and campthotecin synergistically eliminate cancer stem cells in cell-of-origin sarcoma models. Neoplasia (New York, NY). 2017;19(6):460\u201370. https:\/\/doi.org\/10.1016\/j.neo.2017.03.004.","journal-title":"Neoplasia (New York, NY)"},{"issue":"4","key":"5329_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11523-020-00731-z","volume":"15","author":"CR Oh","year":"2020","unstructured":"Oh CR, Hong JY, Kim JH, Lee JS, Kim HS, Kim TW, et\u00a0al. Realworld outcomes of pazopanib treatment in Korean patients with advanced soft tissue sarcoma: a multicenter retrospective cohort study. Target Oncol. 2020;15(4):485\u201393. https:\/\/doi.org\/10.1007\/s11523-020-00731-z.","journal-title":"Target Oncol"},{"issue":"2","key":"5329_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jamcollsurg.2009.10.007","volume":"210","author":"RJ Canter","year":"2010","unstructured":"Canter RJ, Beal S, Borys D, et\u00a0al. Interaction of histologic subtype and histologic grade in predicting survival for soft tissue sarcomas. J Am Coll Surg. 2010;210(2):191\u20138.","journal-title":"J Am Coll Surg"},{"key":"5329_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.05.022","author":"D Winchester","year":"2018","unstructured":"Winchester D, Lehman J, Tello T, et\u00a0al. Undifferentiated pleomorphic sarcoma: factors predictive of adverse outcomes. Am Acad Dermatol. 2018. https:\/\/doi.org\/10.1016\/j.jaad.2018.05.022.","journal-title":"Am Acad Dermatol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05329-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05329-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T11:48:17Z","timestamp":1749210497000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05329-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5329"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05329-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of Guiqian International General Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"268"}}